Moon D G, Yu J W, Lee J G, Kim J J, Koh S K, Cheon J
Department of Urology, Korea University College of Medicine, Seoul, Korea.
BJU Int. 2000 Oct;86(6):670-4. doi: 10.1046/j.1464-410x.2000.00838.x.
To evaluate the influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume (PSAT) and free-to-total PSA ratio (f/tPSA) in detecting prostate cancer in men with intermediate PSA levels of 4.1-10.0 ng/mL.
From March 1997 to June 1999, the f/tPSA and PSAT were measured in 105 patients who underwent ultrasound-guided systemic biopsies and had a PSA level of 4.1-10.0 ng/mL, with an apparently normal prostate on a digital rectal examination. The PSAT and f/tPSA were evaluated in all patients and in subgroups of patients with small (< 40 mL) or large (> or = 40 mL) prostates, using receiver operating characteristic (ROC) curves.
Total prostate volume was highly correlated with transition zone volume in all patients and in both subgroups (P < 0.001). In all 105 patients, PSAT had a sensitivity of 82% and its use would have avoided the largest number of unnecessary biopsies (87% specificity) at a threshold value of 0.35 ng. In men with small prostates f/tPSA and PSAT had a high sensitivity and specificity, at threshold values of 0.12 and 0.35 ng, respectively. In large prostates the PSAT was superior to f/tPSA in detecting prostate cancer.
These results suggest that both f/tPSA and PSAT are useful in detecting prostate cancer in men with small prostates, while PSAT is superior to f/tPSA in detecting prostate cancer in men with large prostates.
评估前列腺体积对经前列腺移行区体积校正的前列腺特异性抗原(PSAT)水平及游离前列腺特异性抗原与总前列腺特异性抗原比值(f/tPSA)在检测前列腺特异抗原水平处于4.1 - 10.0 ng/mL之间男性前列腺癌中的影响。
1997年3月至1999年6月,对105例行超声引导下系统性活检且前列腺特异抗原水平为4.1 - 10.0 ng/mL、直肠指检前列腺外观正常的患者测定f/tPSA和PSAT。使用受试者操作特征(ROC)曲线对所有患者以及前列腺体积小(< 40 mL)或大(≥ 40 mL)的患者亚组中的PSAT和f/tPSA进行评估。
在所有患者及两个亚组中,前列腺总体积与移行区体积高度相关(P < 0.001)。在所有105例患者中,PSAT的敏感性为82%,在阈值为0.35 ng时使用PSAT可避免最多数量的不必要活检(特异性为87%)。在前列腺体积小的男性中,f/tPSA和PSAT分别在阈值为0.12和0.35 ng时具有高敏感性和特异性。在前列腺体积大的男性中,PSAT在检测前列腺癌方面优于f/tPSA。
这些结果表明,f/tPSA和PSAT在检测前列腺体积小的男性前列腺癌中均有用,而在检测前列腺体积大的男性前列腺癌中,PSAT优于f/tPSA。